Establishing Mobile Transcranial Magnetic Stimulation

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Dec 19, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to treat patients with treatment-resistant major depression using a portable device called Transcranial Magnetic Stimulation (TMS). The researchers are setting up a mobile TMS unit in a van and will test it in three locations around South Carolina, all within a two-hour drive from Charleston. The goal is to see if this mobile approach is safe and effective, which could help make TMS treatments more accessible for patients in the future.

To participate in this study, you need to be an adult between the ages of 22 and 80 who has been diagnosed with treatment-resistant depression, meaning that previous treatments haven’t worked for you. You should also be able to read and communicate in English and have access to a computer for initial steps of the trial. However, individuals with certain medical conditions, such as unstable health issues or those who are pregnant, cannot participate. If you join the trial, you can expect to learn more about how this innovative treatment could potentially help improve your condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult (22-80 years old)
• • Have treatment-resistant depression as defined by the e-Mini, and the antidepressant treatment history form (ATHF short).
• • Be able to read and communicate in English.
• • Able to provide their own consent.
• • Access to a computer with videoconferencing ability for initial consent and telescreen.
• Exclusion Criteria:
• • Patients with unstable medical conditions that might make TMS unsafe. This includes current poorly controlled seizures.
• • Ferromagnetic metal in the head.
• • Pregnant.
• • Currently active substance abuse except tobacco.